Clal Biotechnology Industries’ share price gained 8% yesterday after its portfolio company MediWound announced successful Phase III clinical trial results for its flagship product Debrase gel dressing, which is used to treat second- and …
Biolexis is a premiere online resource for life sciences professionals, investors and entrepreneurs. The site offers personalized information biotechnology news and other biotechnology resources. Information is further organized by industry sector, therapeutic areas, technology focus, service orientation, and location. With Biolexis, you can: access over 5,000 biotechnology news strories and biotechnology articles. Search biotech company information, biotech news, biotech articles and biotech related press releases.